Searchable abstracts of presentations at key conferences in endocrinology

ea0011p23 | Bone | ECE2006

The reduction of bone mineral density in post-menopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH hormone secretion impairment

Cecconi E , Genovesi M , Bogazzi F , Grasso L , Procopio M , Marcocci C , Pinchera A , Bartalena L , Martino E , Gasperi M

Primary hyperparathyroidism (PHP) and growth hormone deficiency (GHD) are both associated with alterations of bone metabolism.GH secretion is frequently impaired in PHP patients; thus GH/IGF-I system alterations could be involved in the pathogenesis of osteoporosis.In the present study 50 post-menopausal women with PHP were evaluated by GH response to GH-releasing hormone (GHRH)+arginine (ARG) test and femoral neck bone mineral den...

ea0011p593 | Neuroendocrinology and behaviour | ECE2006

Differentiation of TSH-oma from thyroid hormone resistance syndrome using thyroid color Doppler sonography

Cosci C , Sardella C , Manetti L , Gasperi M , Tomisti L , Gavioli S , Macchia E , Bogazzi F , Martino E

Thyroid hormone resistance (THR) and pituitary TSH-secreting adenomas (TSHoma) are both characterised by increased serum free thyroid hormone levels and normal TSH concentrations. Differentiation of the two syndromes is a clinical challenge, and relies on the suppression (TRH) or lack of suppression (TSHoma) of TSH-dependent parameters and on the presence of germinal mutations in the thyroid hormone receptor beta 1 gene in patients with THR. Thyroid blood flow, evaluated using...

ea0011p614 | Neuroendocrinology and behaviour | ECE2006

Pituitary function in patients with detectable serum pituitary autoantibodies

Morselli LL , Manetti L , Lupi I , Albertini S , Grasso L , Fessehatsion R , Genovesi M , Gasperi M , Martino E

Pituitary autoantibodies have been detected in patients with endocrine autoimmune diseases as well as in various pituitary diseases but their role in determining pituitary dysfunction is not clear. The aim of the present study was to evaluate anterior and posterior pituitary function in a group of patients with detectable pituitary autoantibodies.31 patients (29 women and 2 men) were enrolled in the study: 21 patients affected by Hashimoto’s thyroid...

ea0011p615 | Neuroendocrinology and behaviour | ECE2006

Prevalence of pituitary autoantibodies in thyroid disorders

Manetti L , Morselli LL , Lupi I , Albertini S , Grasso L , Genovesi M , Fessehatsion R , Mariotti S , Martino E

Organ-specific autoantibodies have been detected in patients with autoimmune diseases. The relationship between pituitary autoantibodies and lymphocitic hypophysitis has not yet been established and it is not clear if they are a specific serological marker of the disease.The aim of the present study was to evaluate the prevalence of pituitary autoantibodies in patients affected by autoimmune and nodular thyroid disorders.803 patien...

ea0073oc15.3 | Oral Communications 15: Late Breaking | ECE2021

Targeting PI3K and CDKs as effective therapeutic option for PPGLs in vitro and in vivo

Gulde Sebastian , Martino Daniela De , Mohr Hermine , Satam Swapna , Foscarini Alessia , Nölting Svenja , Pellegata Svenja

Pheochromocytoma and Paraganglioma, collectively referred to as PPGLs, are rare, mostly benign neuroendocrine tumors arising from chromaffin cells of the adrenal gland or of extra-adrenal sites, respectively. Surgery is the first-line therapy for localized PPGLs. However, up to 17% of PPGLs show metastatic spread, and for these cases there is no curative treatment. Therefore, the identification of novel therapeutic approaches for advanced PPGLs is highly clinically relevant. W...

ea0090rc3.3 | Rapid Communications 3: Pituitary and Neuroendocrinology 1 | ECE2023

The spectrum of cardiac disease in patients with acromegaly: results from the SUM trial

De Alcubierre Dario , Feola Tiziana , Cozzolino Alessia , Pofi Riccardo , Pirchio Rosa , Galea Nicola , Cristina De Martino Maria , Pivonello Rosario , Isidori Andrea , Giannetta Elisa

Introduction: Cardiac abnormalities are common in patients with acromegaly and contribute to the increased morbidity and mortality of the disease. Cardiac magnetic resonance (CMR) is the established, non-invasive gold standard for measuring morpho-functional changes of the heart. We aimed to detect cardiac alterations in patients with acromegaly through CMR and to identify potential risk factors associated with cardiac impairment.Materials and methods: T...

ea0063gp141 | Obesity | ECE2019

Dietary inflammatory index is differently associated with ectopic fat depots in overweight and obese adults

Poggiogalle Eleonora , Lubrano Carla , Luisi Federica , Hebert James R , Shivappa Nitin , Di Martino Michele , Gnessi Lucio , Mariani Stefania , Lenzi Andrea , Donini Lorenzo M.

Introduction: In overweight and obesity energy unbalance is responsible for the accumulation of ectopic fat. Excess energy and metabolic alterations, namely insulin resistance, may favor ectopic fat depositions. However, the role played by dietary factors, especially the pro-inflammatory properties of dietary patterns, in ectopic fat storage is not thoroughly understood. The aim of our study was to investigate the association between the Dietary Inflammatory Index (DII) and di...

ea0063p1020 | Interdisciplinary Endocrinology 2 | ECE2019

Circulating miRNAs expression profile in in vitro muscle cell model exposed to cortisol excess

Patalano Roberta , Pivonello Claudia , Monto Tatiana , Simeoli Chiara , Negri Mariarosaria , Di Gennaro Gilda , Papa Fortuna , de Angelis Cristina , Cristina De Martino Maria , Pivonello Rosario

Cushing’s Syndrome (CS) is associated with a severe myopathy mainly affecting type 2 muscle fibres, with a higher prevalence in male subjects. The excess of glucocorticoids (GC) levels represents the most common cause of myopathy due to an alteration of protein metabolism. The non-coding post-transcriptional gene regulators muscle-specific microRNAs (miRNA) control muscle development and differentiation but when dysregulated lead to skeletal muscle (SM) disorder. The aim ...

ea0049ep34 | Adrenal cortex (to include Cushing's) | ECE2017

The treatment with dual release hydrocortisone in patients with adrenal insufficiency: correlation between change of the evening cortisol exposure time profile and change in metabolic profile, depression status and quality of life

Simeoli Chiara , Ferrigno Rosario , Pivonello Claudia , Auriemma Renata Simona , Negri Mariarosaria , Di Gennaro Gilda , Iacuaniello Davide , De Martino Maria Cristina , Colao Annamaria , Pivonello Rosario

Conventional glucocorticoids (CGCs) are unable to mimic physiological cortisol rhythm in adrenal insufficiency (AI), resulting in increased metabolic morbidity and impaired quality of life (QoL). Non-physiological cortisol pattern and elevated evening cortisol levels may be responsible for the increased risk of metabolic disorders observed in AI patients under CGCs. Once daily dual-release-hydrocortisone (DR-HC), which better reproduces physiological daily cortisol profile, si...

ea0049ep713 | Obesity | ECE2017

Dynapenic obesity and myosteatosis in women with and without the metabolic syndrome

Poggiogalle Eleonora , Donini Lorenzo , Gnessi Lucio , Mariani Stefania , Di Martino Michele , Ciccantelli Barbara , Mancini Cecilia , Arca Marcello , Lenzi Andrea , Lubrano Carla

Introduction: Insulin resistance is a well-known hallmark of the metabolic syndrome (MetS), and it detrimentally affects also protein metabolism, favoring to the decline of lean body mass. The aim of the present study was to explore muscle strength (as a functional consequence of sarcopenic obesity) and muscle quality (namely, myosteatosis) in women with and without the Metabolic Syndrome (MetS).Methods: Study participants were enrolled at the Sapienza U...